Literature DB >> 17303067

C-Phycocyanin inhibits 2-acetylaminofluorene-induced expression of MDR1 in mouse macrophage cells: ROS mediated pathway determined via combination of experimental and In silico analysis.

Karnati R Roy1, Kalle M Arunasree, Amit Dhoot, Rachamallu Aparna, Gorla Venkateswara Reddy, Shireen Vali, Pallu Reddanna.   

Abstract

We studied the effects of C-Phycocyanin (C-PC), a biliprotein from Spirulina platensis on the 2-acetylaminofluorene (2-AAF)-induced expression of MDR1, encoded by the multidrug resistance (MDR1) gene, in mouse macrophage cell line (RAW 264.7). Our experimental and In silico studies revealed a significant inhibition of 2-AAF-induced expression of MDR1 protein in C-PC treated mouse macrophage cell line. MDR1 induction by 2-AAF was dependent on ROS (reactive oxygen species)-Akt (protein kinase B)-NF-kappaB (Nuclear factor kappa B) signaling pathway. Generation of ROS, phosphorylation of Akt and corresponding nuclear translocation of NF-kappaB, the events that play a major role in the induction of MDR1 expression, were decreased significantly in C-PC treated cells. NADPH oxidase inhibitor, DPI (Diphenyl iodide), and pharmacological inhibitor of Akt, Akt inhibitor IV, also showed a reduction in MDR1 expression, although not to the same extent as C-PC mediated inhibition of MDR1 expression. To further understand the mechanism, we created a computational model of the detailed ROS-Akt-NF-kappaB pathway. C-PC was modeled purely as a ROS scavenger and this representation matched the experimental trends accurately. Also the ROS levels determined through In silico investigation showed that C-PC was more effective in reduction of MDR1 expression than inhibitors of NADPH oxidase and Akt. Our experimental and In silico studies collectively suggest that 2-AAF induces MDR1 by ROS dependent pathway and C-PC is a potential negative regulator of MDR1 expression. This down regulation of MDR1 expression, induced by xenobiotics such as 2-AAF, suggests C-PC's usefulness in overcoming the drug resistance in cellular systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303067     DOI: 10.1016/j.abb.2007.01.006

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Transcriptional regulation of crystallin, redox, and apoptotic genes by C-Phycocyanin in the selenite-induced cataractogenic rat model.

Authors:  Rasiah Pratheepa Kumari; Srinivasagan Ramkumar; Bency Thankappan; Kalimuthusamy Natarajaseenivasan; Sadhasivam Balaji; Kumarasamy Anbarasu
Journal:  Mol Vis       Date:  2015-01-14       Impact factor: 2.367

2.  Protective role of C-phycocyanin against secondary changes during sodium selenite mediated cataractogenesis.

Authors:  Rasiah Pratheepa Kumari; Kumarasamy Anbarasu
Journal:  Nat Prod Bioprospect       Date:  2014-04-02

3.  Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages.

Authors:  Weibin Zha; Guangji Wang; Weiren Xu; Xuyuan Liu; Yun Wang; Beth S Zha; Jian Shi; Qijin Zhao; Phillip M Gerk; Elaine Studer; Phillip B Hylemon; William M Pandak; Huiping Zhou
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

4.  Lacritin Salvages Human Corneal Epithelial Cells from Lipopolysaccharide Induced Cell Death.

Authors:  Venkat Rao Vantaku; Geetika Gupta; Krishna Chaitanya Rapalli; Roy Karnati
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

5.  Chebulagic acid from Terminalia chebula causes G1 arrest, inhibits NFκB and induces apoptosis in retinoblastoma cells.

Authors:  Naresh Kumar; D Gangappa; Geetika Gupta; Roy Karnati
Journal:  BMC Complement Altern Med       Date:  2014-08-29       Impact factor: 3.659

6.  Spirulina Extract Enhanced a Protective Effect in Type 1 Diabetes by Anti-Apoptosis and Anti-ROS Production.

Authors:  Jiyeong Lee; Arum Park; Mi Jeong Kim; Hee-Joung Lim; Young-Ah Rha; Hee-Gyoo Kang
Journal:  Nutrients       Date:  2017-12-15       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.